Skip to content

Lipoarabinomannan (LAM) Enzyme-Linked Immunosorbent Assay (ELISA) in Diagnostics of Childhood Tuberculosis (TB)

Evaluation of Urine Lipoarabinomannan ELISA In Diagnostics of Childhood Tuberculosis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00512330
Enrollment
250
Registered
2007-08-07
Start date
2007-08-31
Completion date
2008-08-31
Last updated
2008-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Keywords

childhood, tuberculosis, diagnostic, lipoarabinomannan, ELISA, Tuberculosis in Childhood

Brief summary

In children, it remains quite difficult even in developed countries, to prove a diagnosis of Tuberculosis (TB). New means for diagnosis of this disease are currently being researched. One candidate test is Lipoarabinomannan ELISA from Urine, which has shown good sensitivity of up to 80% in adults. Our study aims to evaluate this test in the diagnosis of children with TB.

Detailed description

Among candidate new diagnostics for TB, a test for mycobacterial Lipoarabinomannan (LAM) excretion in urine has shown promising results in one Tanzanian study: The sensitivity for detecting TB culture-positive patients was 80.3%. Of 103 healthy volunteers, only one gave a false positive result (Boehme, 2005). Until now, there are only data concerning this test for diagnosis of adult disease. For evaluation of routine use in children in countries like Malawi, we are starting a prospective study. Children 0-14 years of age with suspected TB will be investigated using TB culture as the gold standard. In sputum samples, microscopy will be done. Simultaneously, LAM Elisa from the patient´s urine will be done.

Interventions

None listed

Sponsors

Our Lady of Mount Carmel Community Hospital, Kapiri, Malawi
CollaboratorUNKNOWN
Ministry of Health and Population, Malawi
CollaboratorOTHER_GOV
Mbeya Medical Research Programme, Mbeya, Tanzania
CollaboratorUNKNOWN
Unterstützerkreis Missionskrankenhaus Kapiri e.V., Munich, Germany
CollaboratorUNKNOWN
Foerderverein AIDS im Kindesalter in Bonn e.V., Bonn, Germany
CollaboratorUNKNOWN
Children's Medical Hospital, University of Bonn, Germany
CollaboratorOTHER
University Hospital, Bonn
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 14 Years
Healthy volunteers
Yes

Inclusion criteria

* age 0-14 years * suspicion of active TB or TB contact

Exclusion criteria

* no informed consent

Countries

Malawi

Contacts

Primary ContactNorbert Heinrich, MD
norbert.heinrich@ukb.uni-bonn.de0049 179 7044231
Backup ContactJohn Chimphamba, Clinical Officer
00265 9394287

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026